Literature DB >> 1671688

Micronuclei with kinetochores in human melanoma cells and rectal carcinomas.

U Weissenborn1, C Streffer.   

Abstract

Micronucleus frequencies were analysed in an X-irradiated human melanoma cell line and in untreated rectal carcinoma cells. As a special aspect of the micronucleus formation, micronuclei-containing kinetochores were analysed by the method of indirect immunofluorescence. The incidence of kinetochore-positive micronuclei was taken as a measure of chromosome loss. In order to show kinetochores, an anti-kinetochore serum of a CREST syndrome patient was used. In irradiated melanoma cells the mean number of micronuclei increased linearly with increasing dose whereas the proportion of kinetochore-positive micronuclei decreased. The analysis of the time-dependent formation of micronuclei revealed an increase of the micronucleus frequency from 24 to 48 h after irradiation (p.r.) and a slight decrease from 48 to 72 h p.r. The highest number of kinetochore-containing micronuclei was scored 72 h p.r. In rectal carcinoma cells a high rate of spontaneously formed micronuclei was observed. At least 30% of these micronuclei contained complete chromosomes, as indicated by the kinetochore-positive staining. We have attempted to summarize the data by means of a numerical expression which takes into account the relation between lost chromosomes, visible as kinetochore-positive micronuclei, and the total sum of micronuclei.

Entities:  

Mesh:

Year:  1991        PMID: 1671688     DOI: 10.1080/09553009114550341

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  2 in total

1.  [Genetic predisposition and radiation sensitivity of normal tissue].

Authors:  C Streffer
Journal:  Strahlenther Onkol       Date:  1997-09       Impact factor: 3.621

2.  The increment of micronucleus frequency in cervical carcinoma during irradiation in vivo and its prognostic value for tumour radiocurability.

Authors:  M Widel; S Jedruś; S Owczarek; M Konopacka; B Lubecka; Z Kołosza
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.